These Big Healthcare Stocks are the Most Liquid in the Sector

Wall St. Watchdog reveals information about the most liquid large cap companies in the Healthcare sector.  Liquidity is measured by the company’s current ratio, which is the ratio of its current assets to its current liabilities.  Current assets are liquid assets that can be readily converted to cash, or which are cash, and current liabilities are those liabilities (debts) due within the next quarter (90 days).  A current ratio higher than one indicates that the company has more current assets than it does current liabilities.  A current ratio lower than one indicates that the company may have trouble paying its short-term debts with cash and cash equivalents on hand.  The minimum market capitalization for this screen is $10 billion.

  • Stryker Corporation (NYSE:SYK): This company has current assets of $7,631,400,000 against current liabilities of $1,605,000,000, for a current ratio of 4.75. The stock recently traded at $46.04 and its market capitalization is $17,878,630,000. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment.
  • Intuitive Surgical, Inc. (NASDAQ:ISRG): This company has current assets of $1,275,800,000 against current liabilities of $273,800,000, for a current ratio of 4.66. The stock recently traded at $328.00 and its market capitalization is $12,819,270,000. About the company: Intuitive Surgical, Inc. design, manufactures and markets surgical systems. The Company’s surgical system controls Intuitive Surgical endoscopic instruments, including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pickups, needle holders, endoscopic retractors, electrocautery, ultrasonic cutters, and accessories during surgical procedures.
  • Celgene Corporation (NASDAQ:CELG): This company has current assets of $4,343,199,000 against current liabilities of $1,070,382,000, for a current ratio of 4.06. The stock recently traded at $51.85 and its market capitalization is $23,789,090,000. About the company: Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
  • Amgen, Inc. (NASDAQ:AMGN): This company has current assets of $23,129,000,000 against current liabilities of $6,570,000,000, for a current ratio of 3.52. The stock recently traded at $48.27 and its market capitalization is $44,605,890,000. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • St. Jude Medical, Inc. (NYSE:STJ): This company has current assets of $2,912,148,000 against current liabilities of $1,017,250,000, for a current ratio of 2.86. The stock recently traded at $40.59 and its market capitalization is $13,348,010,000. About the company: St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.
  • Becton, Dickinson and Co. (NYSE:BDX): This company has current assets of $4,505,250,000 against current liabilities of $1,671,673,000, for a current ratio of 2.70. The stock recently traded at $76.42 and its market capitalization is $16,617,280,000. About the company: Becton, Dickinson and Company manufactures and sells a variety of medical supplies and devices and diagnostic systems. The Company’s products are used by health care professionals, medical research institutions, and the general public. Becton’s products are marketed worldwide.
  • Allergan, Inc. (NYSE:AGN): This company has current assets of $3,993,700,000 against current liabilities of $1,528,400,000, for a current ratio of 2.61. The stock recently traded at $70.36 and its market capitalization is $21,636,540,000. About the company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
  • Biogen Idec Inc. (NASDAQ:BIIB): This company has current assets of $2,540,420,000 against current liabilities of $1,050,122,000, for a current ratio of 2.42. The stock recently traded at $85.03 and its market capitalization is $20,623,670,000. About the company: Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology.  The Company’s products address diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, Crohn’s disease, and psoriasis.
  • Thermo Fisher Scientific Inc. (NYSE:TMO): This company has current assets of $4,135,000,000 against current liabilities of $1,709,800,000, for a current ratio of 2.42. The stock recently traded at $50.00 and its market capitalization is $19,093,650,000. About the company: Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.
  • Gilead Sciences, Inc. (NASDAQ:GILD): This company has current assets of $5,708,082,000 against current liabilities of $2,464,950,000, for a current ratio of 2.32. The stock recently traded at $35.34 and its market capitalization is $27,263,220,000. About the company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases.  The Company’s primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.

(Note: Selected financial data are sourced from screener.co.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet